214 related articles for article (PubMed ID: 28346124)
1. Pax8, Napsin A, and CD10 as Immunohistochemical Markers of Canine Renal Cell Carcinoma.
Peat TJ; Edmondson EF; Miller MA; DuSold DM; Ramos-Vara JA
Vet Pathol; 2017 Jul; 54(4):588-594. PubMed ID: 28346124
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical Profile of 20 Feline Renal Cell Carcinomas.
Ramos-Vara JA; Edmondson EF; Miller MA; Dusold DM
J Comp Pathol; 2017; 157(2-3):115-125. PubMed ID: 28942293
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical Detection of Pax8 and Napsin A in Canine Thyroid Tumours: Comparison with Thyroglobulin, Calcitonin and Thyroid Transcription Factor 1.
Ramos-Vara JA; Frank CB; DuSold D; Miller MA
J Comp Pathol; 2016 Nov; 155(4):286-298. PubMed ID: 27567273
[TBL] [Abstract][Full Text] [Related]
4. Surfactant Protein A and Napsin A in the Immunohistochemical Characterization of Canine Pulmonary Carcinomas: Comparison With Thyroid Transcription Factor-1.
Beck J; Miller MA; Frank C; DuSold D; Ramos-Vara JA
Vet Pathol; 2017 Sep; 54(5):767-774. PubMed ID: 28578631
[TBL] [Abstract][Full Text] [Related]
5. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison.
Ozcan A; de la Roza G; Ro JY; Shen SS; Truong LD
Arch Pathol Lab Med; 2012 Dec; 136(12):1541-51. PubMed ID: 23194047
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic role of immunohistochemical expression of napsin-A aspartic peptidase in clear cell and papillary renal cell carcinoma: a study including 233 primary and metastatic cases.
Xu B; Abourbih S; Sircar K; Kassouf W; Aprikian A; Tanguay S; Brimo F
Appl Immunohistochem Mol Morphol; 2014 Mar; 22(3):206-12. PubMed ID: 23702650
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas.
El-Maqsoud NM; Tawfiek ER; Abdelmeged A; Rahman MF; Moustafa AA
Tumour Biol; 2016 Mar; 37(3):3123-34. PubMed ID: 26427663
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical distinction of renal cell carcinoma from other carcinomas with clear-cell histomorphology: utility of CD10 and CA-125 in addition to PAX-2, PAX-8, RCCma, and adipophilin.
Mentrikoski MJ; Wendroth SM; Wick MR
Appl Immunohistochem Mol Morphol; 2014 Oct; 22(9):635-41. PubMed ID: 25279712
[TBL] [Abstract][Full Text] [Related]
9. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system.
Carvalho JC; Thomas DG; McHugh JB; Shah RB; Kunju LP
Histopathology; 2012 Mar; 60(4):597-608. PubMed ID: 22260386
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
Pan CC; Chen PC; Ho DM
Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
[TBL] [Abstract][Full Text] [Related]
11. Value of PAX8, PAX2, napsin A, carbonic anhydrase IX, and claudin-4 immunostaining in distinguishing pleural epithelioid mesothelioma from metastatic renal cell carcinoma.
Ordóñez NG
Mod Pathol; 2013 Aug; 26(8):1132-43. PubMed ID: 23503645
[TBL] [Abstract][Full Text] [Related]
12. Distinct immunophenotypes and prognostic factors in renal cell carcinoma with sarcomatoid differentiation: a systematic study of 19 immunohistochemical markers in 42 cases.
Yu W; Wang Y; Jiang Y; Zhang W; Li Y
BMC Cancer; 2017 Apr; 17(1):293. PubMed ID: 28449664
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical characterization of 13 canine renal cell carcinomas.
Gil da Costa RM; Oliveira JP; Saraiva AL; Seixas F; Faria F; Gärtner F; Pires MA; Lopes C
Vet Pathol; 2011 Mar; 48(2):427-32. PubMed ID: 20861495
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung.
Ye J; Hameed O; Findeis-Hosey JJ; Fan L; Li F; McMahon LA; Yang Q; Wang HL; Xu H
Biotech Histochem; 2012 Jan; 87(1):30-4. PubMed ID: 21838611
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical diagnosis of renal neoplasms.
Truong LD; Shen SS
Arch Pathol Lab Med; 2011 Jan; 135(1):92-109. PubMed ID: 21204715
[TBL] [Abstract][Full Text] [Related]
16. Histopathologic and Immunohistochemistry Findings in Feline Renal Cell Carcinoma.
Matsumoto I; Chambers JK; Nibe K; Kinoshita R; Nishimura R; Nakayama H; Uchida K
Vet Pathol; 2018 Sep; 55(5):663-672. PubMed ID: 29759053
[TBL] [Abstract][Full Text] [Related]
17. PAX2 and PAX8: useful markers for metastatic effusions.
Waters L; Crumley S; Truong L; Mody D; Coffey D
Acta Cytol; 2014; 58(1):60-6. PubMed ID: 24334997
[TBL] [Abstract][Full Text] [Related]
18. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
Bishop JA; Sharma R; Illei PB
Hum Pathol; 2010 Jan; 41(1):20-5. PubMed ID: 19740516
[TBL] [Abstract][Full Text] [Related]
19. Napsin A expression in lung and kidney neoplasia: a review and update.
Ordóñez NG
Adv Anat Pathol; 2012 Jan; 19(1):66-73. PubMed ID: 22156835
[TBL] [Abstract][Full Text] [Related]
20. Immunoexpression of napsin A in renal neoplasms.
Zhu B; Rohan SM; Lin X
Diagn Pathol; 2015 Mar; 10():4. PubMed ID: 25889632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]